Spots Global Cancer Trial Database for stage iiic breast cancer
Every month we try and update this database with for stage iiic breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer | NCT00238290 | Breast Cancer | Trastuzumab + L... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | NCT01824836 | Estrogen Recept... Musculoskeletal... Progesterone Re... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | anastrozole questionnaire a... laboratory biom... pharmacogenomic... | 18 Years - | Eastern Cooperative Oncology Group | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy | NCT01487954 | Radiation Toxic... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | alkaline water distilled water external beam r... | 18 Years - | Case Comprehensive Cancer Center | |
| Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus | NCT02015559 | Estrogen Recept... HER2-negative B... Oral Complicati... Progesterone Re... Recurrent Breas... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | mucoadhesive or... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic | NCT00003440 | HER2-negative B... HER2-positive B... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | paclitaxel trastuzumab quality-of-life... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | NCT00093795 | Breast Cancer | Cyclophosphamid... Docetaxel Gemcitabine Paclitaxel Doxorubicin | 18 Years - | NSABP Foundation Inc | |
| Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery | NCT00305825 | Breast Cancer | bevacizumab letrozole | 18 Years - 120 Years | University of California, San Francisco | |
| Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors | NCT01113554 | Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | questionnaire a... exercise interv... quality-of-life... survey administ... management of t... psychosocial as... | 18 Years - | Wake Forest University Health Sciences | |
| Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer | NCT00337233 | Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef... | yoga therapy | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment | NCT01573442 | Arthralgia Breast Cancer Hot Flashes Musculoskeletal... Sexual Dysfunct... | testosterone placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission | NCT00227474 | Breast Cancer | recombinant mod... adjuvant therap... recombinant vir... | 18 Years - | SWOG Cancer Research Network | |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer | NCT03102866 | Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Best Practice Exercise Interv... Quality-of-Life... Questionnaire A... | - | Ohio State University Comprehensive Cancer Center | |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer | NCT02827877 | HER2 Positive B... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Copper Cu 64-DO... Laboratory Biom... Pertuzumab Positron Emissi... Therapeutic Con... Trastuzumab | 18 Years - | City of Hope Medical Center | |
| Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00107510 | Breast Cancer | pegfilgrastim carboplatin docetaxel conventional su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic | NCT00003440 | HER2-negative B... HER2-positive B... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | paclitaxel trastuzumab quality-of-life... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | NCT00450892 | Breast Cancer | docetaxel+lapat... docetaxel + tra... docetaxel + tra... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. | NCT00127205 | Breast Cancer | clodronate diso... ibandronate sod... zoledronic acid | 18 Years - | SWOG Cancer Research Network | |
| Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors | NCT03039140 | Cancer Survivor Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A... | 30 Years - 75 Years | Ohio State University Comprehensive Cancer Center | |
| Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer | NCT01385280 | Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | therapeutic est... exemestane laboratory biom... enzyme-linked i... | - | University of Arizona | |
| Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | NCT00331630 | Breast Cancer | lapatinib ditos... paclitaxel albu... | 18 Years - | Northwestern University | |
| Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | NCT02023008 | Anxiety Disorde... Depression Ductal Breast C... Fatigue Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | yoga therapy internet-based ... questionnaire a... | 18 Years - | Wake Forest University Health Sciences | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32 | NCT01666171 | Breast Cancer | metformin hydro... clinical observ... diagnostic labo... imaging biomark... medical chart r... digital mammogr... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | NCT00362973 | Breast Cancer | laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose... | 18 Years - 120 Years | University of Washington | |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | NCT00080860 | Breast Cancer | microarray anal... immunohistochem... conventional su... lymphangiograph... radionuclide im... sentinel lymph ... technetium Tc 9... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer | NCT00489125 | Breast Cancer | physiologic tes... | - 120 Years | Wake Forest University Health Sciences | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | NCT00054145 | Breast Cancer | perifosine | 18 Years - | University Health Network, Toronto | |
| Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer | NCT00075413 | Breast Cancer | arsenic trioxid... | 18 Years - 120 Years | The University of Texas Medical Branch, Galveston | |
| Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | NCT01705340 | Adenocarcinoma ... HER2-positive B... Male Breast Can... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Stage IIIC Brea... Stage IIIC Esop... Stage IIIC Gast... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... | Akt inhibitor M... trastuzumab lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
| Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | NCT00309920 | Breast Cancer | darbepoetin alf... cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | NCT00066378 | Breast Cancer | anastrozole gefitinib | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer | NCT00689975 | Breast Cancer | behavioral diet... exercise interv... counseling inte... flow cytometry immunoenzyme te... laboratory biom... complementary o... standard follow... | - | National Cancer Institute (NCI) | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | NCT00424164 | Breast Cancer | lapatinib ditos... tamoxifen citra... pharmacological... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer | NCT00022230 | Breast Cancer | aldesleukin filgrastim sargramostim therapeutic aut... cyclophosphamid... doxorubicin hyd... paclitaxel | 18 Years - | Roger Williams Medical Center | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | NCT00834678 | Breast Cancer | bendamustine erlotinib Maintenance erl... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer | NCT00641303 | Anxiety Disorde... Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders | acupuncture the... sham interventi... | 18 Years - | University of Maryland, Baltimore | |
| Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer | NCT00060320 | Breast Cancer Hot Flashes | black cohosh placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery | NCT01292083 | Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Triple-negative... | azacitidine laboratory biom... immunohistochem... polymerase chai... western blottin... nucleic acid se... therapeutic con... | 18 Years - | University of Southern California | |
| Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | NCT02060253 | HER2-positive B... Male Breast Can... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | ganetespib paclitaxel trastuzumab pertuzumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Acupuncture in Treating Hot Flashes in Women With Breast Cancer | NCT00081965 | Breast Cancer Hot Flashes | acupuncture the... hot flashes att... management of t... | - | Memorial Sloan Kettering Cancer Center | |
| Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | NCT00290732 | Breast Cancer | Intraductal arm Intravenous arm | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior | NCT01000883 | Breast Cancer | biologic sample... laboratory biom... biopsy | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers | NCT01043003 | Breast Cancer Ductal Breast C... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | educational int... quality-of-life... Questionnaire A... psychosocial su... assessment of t... informational i... | 18 Years - | City of Hope Medical Center | |
| Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | NCT00044993 | Breast Cancer | Ad5CMV-p53 gene docetaxel doxorubicin hyd... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 | NCT00544804 | Breast Cancer Metastatic Canc... | lapatinib ditos... gene expression... diagnostic labo... | 18 Years - | University of California, San Francisco | |
| Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer | NCT00238290 | Breast Cancer | Trastuzumab + L... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| Improving Communication With Patients With Breast Cancer | NCT00276822 | Breast Cancer | communication i... | 30 Years - 80 Years | Northwestern University | |
| Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer | NCT00066443 | Breast Cancer | pegfilgrastim docetaxel epirubicin hydr... | 16 Years - | Canadian Cancer Trials Group | |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer | NCT00937989 | Breast Cancer | educational int... informational i... medical chart r... questionnaire a... study of socioe... quality-of-life... | 50 Years - | City of Hope Medical Center | |
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | NCT00824538 | Breast Cancer | sunitinib malat... flow cytometry immunohistochem... laboratory biom... | 18 Years - 120 Years | University of California, San Francisco | |
| Collecting and Storing Tissue Samples From Women With or Without Breast Cancer | NCT00899301 | Breast Cancer | biologic sample... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer | NCT00856492 | Breast Cancer | bevacizumab pegfilgrastim cyclophosphamid... doxorubicin hyd... paclitaxel albu... | 18 Years - | SWOG Cancer Research Network | |
| Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer | NCT01086605 | Breast Cancer | pixantrone dima... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer | NCT00641303 | Anxiety Disorde... Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders | acupuncture the... sham interventi... | 18 Years - | University of Maryland, Baltimore | |
| Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) | NCT03025139 | Cancer Survivor Early-Stage Bre... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Laboratory Biom... Meditation Ther... Questionnaire A... | - 49 Years | Jonsson Comprehensive Cancer Center | |
| Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy | NCT00722072 | Breast Cancer | fulvestrant sorafenib tosyl... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| CADY Study ICORG 08-01 | NCT00968682 | Breast Cancer Cardiac Toxicit... | trastuzumab laboratory biom... assessment of t... | 18 Years - | Cancer Trials Ireland | |
| Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer | NCT02400060 | Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage 0 Breast ... | Telephone-Based... Survey Administ... Laboratory Biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | NCT01194440 | Ductal Carcinom... Estrogen Recept... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | letrozole zoledronic acid | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | NCT00301899 | Breast Cancer | pertuzumab trastuzumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PET Scans in Patients With Locally Advanced Breast Cancer | NCT00109785 | Breast Cancer | positron emissi... fludeoxyglucose... iodine I 124 io... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
